177 related articles for article (PubMed ID: 31837226)
21. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
[TBL] [Abstract][Full Text] [Related]
22. Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
Perkovic V; Toto R; Cooper ME; Mann JFE; Rosenstock J; McGuire DK; Kahn SE; Marx N; Alexander JH; Zinman B; Pfarr E; Schnaidt S; Meinicke T; von Eynatten M; George JT; Johansen OE; Wanner C;
Diabetes Care; 2020 Aug; 43(8):1803-1812. PubMed ID: 32444457
[TBL] [Abstract][Full Text] [Related]
23. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Gezer M; Taş A; Eyileten T; Guler AK; Aydin İ; Oguz Y; Tarim K; Covic A; Yilmaz MI
Eur J Intern Med; 2016 Sep; 33():81-7. PubMed ID: 27394925
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker.
Pontillo C; Zhang ZY; Schanstra JP; Jacobs L; Zürbig P; Thijs L; Ramírez-Torres A; Heerspink HJL; Lindhardt M; Klein R; Orchard T; Porta M; Bilous RW; Charturvedi N; Rossing P; Vlahou A; Schepers E; Glorieux G; Mullen W; Delles C; Verhamme P; Vanholder R; Staessen JA; Mischak H; Jankowski J
Kidney Int Rep; 2017 Nov; 2(6):1066-1075. PubMed ID: 29130072
[TBL] [Abstract][Full Text] [Related]
25. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
[TBL] [Abstract][Full Text] [Related]
26. Association of Body Weight Variability with Adverse Cardiovascular Outcomes in Patients with Pre-Dialysis Chronic Kidney Disease.
Suh SH; Oh TR; Choi HS; Kim CS; Bae EH; Park SK; Kim YS; Kim YH; Choi KH; Oh KH; Ma SK; Kim SW; On Behalf Of The KoreaN Cohort Study For Outcomes In Patients With Chronic Kidney Disease Know-Ckd Investigators
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684382
[TBL] [Abstract][Full Text] [Related]
27. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Aging (Albany NY); 2021 Oct; 13(19):22690-22709. PubMed ID: 34629330
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study.
Degenaar A; Jacobs A; Kruger R; Delles C; Mischak H; Mels C
BMC Nephrol; 2023 Apr; 24(1):96. PubMed ID: 37055746
[TBL] [Abstract][Full Text] [Related]
29. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.
Lindhardt M; Persson F; Currie G; Pontillo C; Beige J; Delles C; von der Leyen H; Mischak H; Navis G; Noutsou M; Ortiz A; Ruggenenti PL; Rychlik I; Spasovski G; Rossing P
BMJ Open; 2016 Mar; 6(3):e010310. PubMed ID: 26936907
[TBL] [Abstract][Full Text] [Related]
30. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
[TBL] [Abstract][Full Text] [Related]
31. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
[TBL] [Abstract][Full Text] [Related]
33. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Saglam M; Demirbas S; Verim S; Unal HU; Gaipov A; Oguz Y; Kayrak M; Caglar K; Vural A; Turk S; Covic A; Kanbay M
Nephrology (Carlton); 2013 Nov; 18(11):728-35. PubMed ID: 23848392
[TBL] [Abstract][Full Text] [Related]
34. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.
Garofolo M; Russo E; Miccoli R; Lucchesi D; Giusti L; Sancho-Bornez V; Daniele G; Del Prato S; Penno G
J Diabetes Complications; 2018 Jun; 32(6):550-557. PubMed ID: 29705091
[TBL] [Abstract][Full Text] [Related]
35. Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients.
Palau V; Riera M; Duran X; Valdivielso JM; Betriu A; Fernández E; Pascual J; Soler MJ
Nephrol Dial Transplant; 2020 Jan; 35(1):130-138. PubMed ID: 30102333
[TBL] [Abstract][Full Text] [Related]
36. Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Ruilope LM; Agarwal R; Anker SD; Bakris GL; Filippatos G; Nowack C; Kolkhof P; Joseph A; Mentenich N; Pitt B;
Am J Nephrol; 2019; 50(5):345-356. PubMed ID: 31665733
[TBL] [Abstract][Full Text] [Related]
37. Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia.
Nseir W; Artul S; Nasrallah N; Mograbi J; Mahamid M
J Diabetes; 2016 Jul; 8(4):502-7. PubMed ID: 26040706
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
39. Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease.
Quiroga B; Galán I; García de Vinuesa S; Goicoechea M; Verdalles Ú; Luño J
Nephrol Dial Transplant; 2015 May; 30(5):801-6. PubMed ID: 25753805
[TBL] [Abstract][Full Text] [Related]
40. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
